Direct evidence of nitric oxide release from neuronal nitric oxide synthase activation in the left ventricle as a result of cervical vagus nerve stimulation
Open Access
- 12 June 2009
- journal article
- Published by Wiley in The Journal of Physiology
- Vol. 587 (12) , 3045-3054
Abstract
Information regarding vagal innervation in the cardiac ventricle is limited and the direct effect of vagal stimulation on ventricular myocardial function is controversial. We have recently provided indirect evidence that the anti‐fibrillatory effect of vagus nerve stimulation on the ventricle is mediated by nitric oxide (NO). The aim of this study was to provide direct evidence for the release of nitric oxide in the cardiac ventricle during stimulation of the efferent parasympathetic fibres of the cervical vagus nerve. The isolated innervated rabbit heart was employed with the use of the NO fluorescent indicator 4,5‐diaminofluorescein diacetate (DAF‐2 DA) during stimulation of the cervical vagus nerves and acetylcholine perfusion in the absence and presence of the non‐specific NO synthase inhibitor NG‐nito‐l‐arginine (l‐NNA) and the neuronal NO synthase selective inhibitor 1‐(2‐trifluormethylphenyl)imidazole (TRIM). Using the novel fluorescence method in the beating heart, we have shown that NO‐dependent fluorescence is increased by 0.92 ± 0.26, 1.20 ± 0.30 and 1.91 ± 0.27% (during low, medium and high frequency, respectively) in the ventricle in a stimulation frequency‐dependent manner during vagus nerve stimulation, with comparable increases seen during separate stimulation of the left and right cervical vagus nerves. Background fluorescence is reduced during perfusion with l‐NNA and the increase in fluorescence during high frequency vagal stimulation is inhibited during perfusion with both l‐NNA (1.97 ± 0.35% increase before l‐NNA, 0.00 ± 0.02% during l‐NNA) and TRIM (1.78 ± 0.18% increase before TRIM, −0.11 ± 0.08% during TRIM). Perfusion with 0.1 μm acetylcholine increased NO fluorescence by 0.76 ± 0.09% which was blocked by l‐NNA (change of 0.00 ± 0.03%) but not TRIM (increase of 0.82 ± 0.21%). Activation of cardiac parasympathetic efferent nerve fibres by stimulation of the cervical vagus is associated with NO production and release in the ventricle of the rabbit, via the neuronal isoform of nitric oxide synthase.Keywords
This publication has 44 references indexed in Scilit:
- Nitric oxide mediates the vagal protective effect on ventricular fibrillation via effects on action potential duration restitution in the rabbit heartThe Journal of Physiology, 2007
- Autonomic Nerve Stimulation Reverses Ventricular Repolarization Sequence in Rabbit HeartsCirculation Research, 2007
- Cardiomyocyte-Restricted Overexpression of Endothelial Nitric Oxide Synthase ( NOS3 ) Attenuates β-Adrenergic Stimulation and Reinforces Vagal Inhibition of Cardiac ContractionCirculation, 2004
- The preferential β3‐adrenoceptor agonist BRL 37344 increases force viaβ1‐/β2‐adrenoceptors and induces endothelial nitric oxide synthase viaβ3‐adrenoceptors in human atrial myocardiumBritish Journal of Pharmacology, 2003
- Decreased Contractility of the Left Ventricle is Induced by the Neurotrausmitter Acetylcholine, but not by Vagal Stimulation in Rats.Japanese Heart Journal, 2003
- Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the catActa Physiologica Scandinavica, 2001
- Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarctionThe Lancet, 1998
- Endogenous Protection Against Reperfusion-induced Ventricular Fibrillation: Role of Neuronal versus Non-neuronal Sources of Nitric Oxide and Species Dependence in the Rat versus Rabbit Isolated HeartJournal of Molecular and Cellular Cardiology, 1996
- Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs.Journal of Clinical Investigation, 1995
- Functional anatomy of canine cardiac nervesCells Tissues Organs, 1975